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Abstract

Correlation Between Pluripotent Stem Cell Markers and microRNA
Expression in Dental Pulp Stem Cells

By

Mark Whiting

Dr. Karl Kingsley, Examination Committee Chair
Associate Professor of Biomedical Sciences
Director of Student Research
University of Nevada, Las Vegas
School of Dental Medicine

In human development there are many factors that cause our cells to form certain organs
and systems with specific functions. These cells original start as stem cells before biological
processes take over and cause differentiation into different cell lines. Since these
undifferentiated stem cells have been discovered, many studies have been done to try and find
the exact mechanism that causes a cell to change into another specific cell. Due to the multiple
sources that stem cells can be harvest from the human body, this knowledge of how
differentiation works could lead to breakthroughs in regenerative medicine.
Traditional biomarkers have been the focus of much research in identifying
characteristics of stem cells. Biomarkers include Oct-4, Sox-2, NANOG, and Nestin. The
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aforementioned biomarkers have been shown to identify stem cells that have pluripotent
properties with potential to differentiate.
MicroRNA (miRNA) are small nucleotide chains that have been the topic of
research in recent years. These chains have been shown to be involved in affecting gene
expression and silencing. Thi

The data for the following two studies provide evidence of the existence of certain
miRNAs in a unique source of stem cells, specifically dental pulp stem cells (DPSC). The
miRNA molecules investigated in these DPSCs include miR-16, miR-27, miR-124, miR-135,
and miR-218. Evidence suggests the presence of specific miRNA in certain DPSC lines which
include miR-16, miR-27, miR-124 and miR-218. With differential expression of miR-27, miR124 and miR-218 in our different DPSC lines, evidence suggest these miRNA may impact the
cells potential for differentiation.
Furthermore, these miRNA molecules were cross-referenced with the expression
of certain characteristics of these DPSC line. Characteristics include the presence of biomarkers
Oct-4, Sox-2, NANOG and Nestin. In addition, we also looked at their relation to the DPSC lines
viability and proliferation rates. Our results have shown that biomarkers Oct-4, Sox-2 and Nanog
correlated more with total live cell count whereas miRNAs miR-27, miR218, miR-124 and miR16 were more closely related to cellular viability. Further research will be needed to more fully
understand the relationship.
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Chapter 1: Introduction
Background and Significance
Stem cells have been the topic of much research in recent years due to their unique
biological properties. Their stemness and pluripotent properties make them ideal tools in
regenerative medicine and scientists have found many sources of stem cells in the human
body.[1-3] These sources include bone marrow, adipose tissue, periodontal tissue, heart tissue,
peripheral blood and dental pulp cells.[4-8] Dental pulp stem cells (DPSC) are unique in their
ease of access compared to other stem cells and are the focus of our research.
Past research has been done focusing on the analysis of several key biomarkers as they
relate to pluripotency such as Oct-4, Sox-2, and NANOG.[9-10] Although the study of these
biomarkers has helped to better understand DPSC, there is still much that is unknown. We hoped
to expand on our knowledge through the evaluation of microRNA as they pertain to DPSC.
MicroRNA molecules are small non-coding RNA molecules involved in repression and
activation of transcriptional factors in stem cells.[11-12] MicroRNA molecules have been shown
to be involved in cellular differentiation and in altering expression of certain cell lineage. Their
inclusion in this study will hopefully help to better understand DPSC and their usefulness in
regenerative medicine.
Research Question
Based upon the paucity of evidence regarding miRNA expression among DPSC, the primary
goal for this study was to evaluate expression of several key miRNAs, including miR-16, miR27, miR-124, and miR218

1.

Can microRNAs be detected in RNA isolated from primary DPSC explant?
1

H0: No microRNA will be detectable from RNA isolated from DPSC explant.
HA: MicroRNA will be detectable from RNA isolated from DPSC explants.
2.

Is there a correlation between microRNA expression and DPSC biomarkers or cellular
phenotypes?
H0: There are no correlations between microRNA expression and DPSC biomarkers or
cellular phenotypes.
HA: There are correlations between microRNA expression and DPSC biomarkers or cellular
phenotypes.

Approval
This project was reviewed and approved by the Institutional Review Board(IRB) office
and the Protection of Human Subject (OPRS) under protocol OPRS#763012analysis of dental pulp stem cells (DPCS) from at the University of Nevada, Las Vegas

using protocol OPRS#0907-

ion of Non-
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Chapter 2
Expression of microRNA miR-27, miR-124 and miR-218 Among Dental Pulp Stem Cell (DPSC)
Isolates
Current Research in Dentistry , An Int. Journal, and is
presented in the style of that Journal. The complete Citation is:
Whiting M, Kingsley K. Expression of microRNA miR-27, miR-124 and miR-218 Among
Dental Pulp Stem Cell (DPSC) Isolates. Current Research in Dentistry vol 9: 12-18, 2018;
DOI:10.3844/crdsp.2018.12.18.
Role of Authors:
This work was carried out in collaboration between all authors. Author Mark Whiting was
responsible for sample preparation, RNA isolation and experimental protocol. Authors Dr. Karl
Kingsley and Dr. Mark Whiting were responsible for project design, funding and manuscript
preparation. All authors read and approved the final manuscript.
Abstract
Dental Pulp Stem Cells (DPSCs) are non-embryonic, mesenchymal stem cells that may
have significant potential for therapeutic and regenerative biomedical applications. MicroRNAs
are small non-coding RNA molecules that can act as transcriptional activators and repressors in
many types of mesenchymal stem cells. To date, few studies have evaluated the expression or
activity of microRNAs among dental pulp stem cells. Using eight previously isolated and
characterized DPSC lines, RNA was extracted and examined using PCR to determine expression
of several key miRNAs, including miR-16, miR-27, miR-124, miR-135, miR-143 and miR-218.
These data demonstrated that at least four of these microRNAs are active among some of these
DPSC isolates, including miR-16, miR-27, miR-124 and miR-218. Although the transcriptional
targets of these miRNAs are not yet known, it is evident that the differential expression of some
of these miRNAs (miR-27, miR-124, miR-218) may correlate (or even contribute) to
differentiation status of these isolates. More research will be needed to determine the precise
5

function and targets of these microRNAs to determine their effects on DPSC differentiation, which
may foster biotechnology applications for DPSC bioengineering applications.

Key words: Dental pulp stem cell (DPSC), microRNA, cellular differentiation,
bioengineering

Abbreviations: dental pulp stem cells (DPSC), mesenchymal stem cells (MSC), Institutional
Review Board (IRB), Office for the Protection of Human Subjects (OPRS), University of
Nevada, Las Vegas School of Dental Medicine (UNLV-SDM), microRNAs (miR), cementoenamel junction (CEJ), total RNA isolation reagent (TRIR), Polymerase chain reaction
(PCR), doubling time (DT), rapid doubling times (rDT), slow doubling times (sDT),
intermediate doubling times (iDT), phosphate buffed saline (PBS)
Introduction
Dental Pulp Stem Cells (DPSCs) are non-embryonic, mesenchymal stem cells that may have
significant potential for therapeutic and regenerative biomedical applications (Hollands et al., 2018;
Ledesma-Martínez et al., 2016; Kabir et al., 2014). Many of these research studies regarding these
potential treatments have focused on dental and oral tissues (Hernández-Monjaraz et al., 2018;
Aurrekoetxea et al., 2015; Duncan et al., 2016). However, other research has suggested that DPSC may
be useful to biomedical engineering and tissue regeneration efforts for tissues outside of the oral cavity or
head and neck tissues (Daltoé et al., 2014; Collart-Dutilleul et al., 2015; Mead et al., 2017; Victor and
Reiter, 2017).
Although much has been discovered regarding the regenerative potential of DPSC, many facets of
DPSC isolation and differentiation have yet to be elucidated (Zainuri et al., 2018; Bakopoulou et al.,
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2017; Bakkar et al., 2017). For example, some evidence may suggest the method of isolation may
influence the stem cell properties and alter the differentiation potential of DPSC isolates (Hilkens et al.,
2013; Karamzadeh et al., 2012; Rodríguez-Lozano et al., 2012). However, due to the recent discovery of
DPSCs and their regenerative potential, much remains to be discovered regarding the mechanisms that
may control differentiation, such as epigenetic regulation-which have been more extensively studied in
other types of Mesenchymal Stem Cells (MSC) (Saidi et al., 2017; Ozkul and Galderisi, 2016; Deng et
al., 2015).
MicroRNAs are small non-coding RNA molecules that can act as transcriptional activators and
repressors in many types of mesenchymal stem cells (Katsuda and Ochiya, 2015; Utikal et al., 2015;
Huang et al., 2016; Martin et al., 2016) Some microRNAs (miR), such as miR-21 and miR-16 appear to
be significant biomarkers and modulators of MSC potential and differentiation (Sekar et al., 2015; Clark
et al., 2014; Fakhry et al., 2013). To date, few studies have evaluated the expression or activity of
microRNAs among dental pulp stem cells

(Tu et al., 2018; Sun et al., 2017; Li et al., 2015).

Based upon the paucity of evidence regarding miRNA expression among DPSC, the primary goal
of this study was to evaluate expression of several key miRNAs, including miR-16, miR-27, miR-124,
miR-135, miR-143 and miR-218.

Methodology
Project approval
The review and approval for this project was facilitated by the Office for the Protection of
Research Subjects (OPRS) and Institutional Review Board (IRB) OPRS#763012analysis of Dental Pulp Stem Cells (DPSC) from the University of Nevada Las Vegas (UNLV) School of

the DPSC samples was approved by the IRB and OPRS under protocol OPRS#0907Non-
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In brief, adult patients that were scheduled for an extraction in the clinic prior to
Orthodontic treatment (mainly for spacing issues) were asked to provide Informed Consent in
order to participate. Any patients having teeth extracted due to other reasons, which included
injury (fracture) or compromised dental pulp, pulp infection or disease, were excluded from
participation

DPSC Isolation
The original isolation of the dental pulp from the pulp chamber following extraction involved
cross sectioning of the extracted tooth (pre-molar or third molar) at the Cemento-Enamel Junction (CEJ),
following by extraction of the dental pulp with an endodontic broach, that was subsequently placed into a
sterile microcentrifuge tube containing Phosphate Buffered Saline (PBS) for transfer to the biomedical
laboratory (Alleman et al., 2013; Hung et al., 2013).

In brief, each DPSC isolate was allowed to grow for ten passages using the direct
outgrowth method and the rate of growth or Doubling Time (DT) was evaluated and assessed as
the interval between 1:4 pass aging and achieving confluence. The analysis of DPSC isolate
growth allowed for the identification of three distinct rates of DPSC growth, rapid Doubling
Times (rDT) less than three days, slow Doubling Times (sDT) of greater than one week (8-10
days) and a smaller subset with intermediate Doubling Times (iDT) (Young and Kingsley, 2015;
Tomlin et al., 2016). Each DPSC isolate was then cryopreserved at -80C for future analysis and
experimentation.

RNA isolation
For the current project, DPSC isolates were removed from storage and RNA was
extracted from an aliquot of each DPSC isolate using 1.0 107 cells using the total RNA isolation
8

reagent (TRIR) from Molecular Research Center, Inc. (Cincinnati, OH) using the protocol
recommended by the manufacturer. The quantification of RNA concentration and purity was
then assessed using spectrophotometric analysis of each sample at 260 and 280 nm. The ratio of
A260:A280 measurements provide a measurement of RNA purity (acceptable range between
1.7-2.0) and a general estimate of quantity.
All isolates with sufficient quality (A260:A280 > 1.7) and quantity (> 1 n/guL) were
processed and screened for microRNA biomarker expression as previously described (Petersen
and Kingsley, 2016; Brennan et al., 2018). Mesenchymal Stem Cell (MSC) biomarkers used in
this screening included several previously validatedmiR-27, miR-124, miR-135, miR-143 and
miR-218, as well as the internal validation control, miR-16, as follows:
miR-

-TAGCAGCACGTAAATATTGGCG-TGCGTGTCGTGGAGTC-

miR-

-16
PCR): 54.3°C

-ATATGAGAAAAGAGCTTCCCTGTG-

-27

Optimal Tm (PCR): 56.2°C

miR-124-

-ATGAATTCTCGCCAGCTTTTTCTT-

reverse: 5 -ATGAATTCATTTGCATCTGCACAAACCCOptimal Tm (PCR): 54.4°C

miR-

-CGATATGGCTTTTTATTCCTA -

miR-

-GAGCAGGGTCCGAGGT -
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-124

Optimal Tm (PCR): 49.8°C
miR-

-AGTGCGTGTCGTGGAGTC-

miR-

-GCCTGAGATGAAGCACTGT-

Optimal Tm (PCR): 54.6°C

miR-

-TCG GGC TTG TGC TTG ATC T-

miR-

-GTG CAG GGT CCG AGT G-

Optimal Tm (PCR): 61°C

Results
To screen for the expression of specific non-coding RNA, total RNA was isolated from
each DPSC and quantified to determine any differences in total RNA expression among the
DPSC isolates (Table 1). These data revealed that total RNA obtained from DPSC isolates with
rapid, slow and intermediate doubling times (rDT, iDT, sDT) were similar, p = 0.9646. More
specifically, the average total RNA isolated from each type of DPSC isolate was not significantly
different

although two isolates (dpsc-5653 rDT, dpsc-11418 sDT) had total RNA extraction

values that were slightly lower than the majority of DPSC isolates.
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Table 1. RNA isolation and concentration from DPSC isolate
DPSC isolate

RNA quantification

rDT

912.8 ng/uL +/- 22.5

iDT

929.8 ng/uL +/- 5.9

d.f.=2

sDT

913.5 ng/uL +/- 36.1

p=0.9646

dpsc-3882 (rDT)

921.1 ng/uL

dpsc-5653 (rDT)

887.3 ng/uL

dpsc-7089 (rDT)

930.1 ng/uL

dpsc-8124 (iDT)

925.6 ng/uL

dpsc-17322 (iDT)

933.9 ng/uL

dpsc-11418 (sDT)

879.4 ng/uL

dpsc-11750 (sDT)

910.0 ng/uL

dpsc-11836 (sDT)

951.2 ng/uL

Range: 879.4

Statistical analysis
=0.072

951.2 ng/uL

Average: 917.3 ng/uL

Following the successful isolation of RNA from all DPSC isolates with sufficient
concentration for analysis, an assessment of the RNA quality was performed to determine the
suitability of this RNA for subsequent PCR screening (Table 2). These data revealed the RNA
purity (measured by the ratio of absorbance readings at 260 and 280 nm) was sufficient for PCR
screening and analysis (A260:A280>1.65), with no significant differences observed between
11

rDT, iDT and sDT averages, p = 0.4849. Only one DPSC isolate (dpsc-3882 rDT) was found to
be slightly below the commonly accepted average purity standard (A260:A280 = 1.54).
Table 2. RNA purity from DPSC isolates
DPSC isolate

RNA purity (A260:A280)

Statistical analysis

rDT

1.67

iDT

1.77

d.f.=2

sDT

1.84

p=0.4849

dpsc-3882 (rDT)

1.54

dpsc-5653 (rDT)

1.77

dpsc-7089 (rDT)

1.72

dpsc-8124 (iDT)

1.65

dpsc-17322 (iDT)

1.89

dpsc-11418 (sDT)

1.91

dpsc-11750 (sDT)

1.83

dpsc-11836 (sDT)

1.79

Range: 1.54-1.91
Average: 1.76
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=1.447

Following the characterization of RNA obtained from each DPSC isolate, RT-PCR was
utilized to screen the RNA for expression of non-coding microRNA (Fig. 1). These data revealed
that all DPSC isolates expressed miR-16 (positive control), as expected. Screening for the
additional microRNAs revealed differential expression of miR-27, miR-124 and miR-218. More
specifically, miR-27 expression was observed among the rDT but not the iDT or SDTDPSC
isolates. In contrast, miR-124 expression was observed only among the sDT but not the rDT or
iDT DPSC isolates. However, miR-218 was expressed among all the sDT and one of the rDT
DPSC isolates but not among the iDT isolates. No expression of miR-135 or miR-143 was
observed among any DPSC isolate screened.
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Fig1. Expression of miRNA among DPSC isolates. Screening for miRNA among eight DPSC
isolates revealed expression of miR-16 (positive control) among all DPSC isolates and
differential expression of miR-27, miR-124 and miR-218. No expression was observed for miR135 or miR-143 (data not shown)
Discussion
Based upon the paucity of evidence regarding miRNA expression among DPSC, the
primary goal of this study was to evaluate expression of several key miRNAs, including miR-16,
miR-27, miR-124, miR-135, miR-143 and miR-218. The results of this pilot study have revealed
that RNA could be successfully isolated and screened for microRNA expression among all the
DPSC isolates. Furthermore, although the expression of the positive control microRNA (miR-16)
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was observed among all DPSC isolates, differential or lack of expression was observed among
each of the remaining microRNAs (Yu et al., 2013; Eguchi et al., 2013).
These results are significant as the evidence for microRNA expression among DPSC
isolates is in the very early stages of exploration and few studies to date have evaluated this
phenomenon (Tu et al., 2018;

Sun et al., 2017; Li et al., 2015). This study screened for miR-

143 and miR-135 expression, which was demonstrated to function in the pathway for myogenic
differentiation of DPSC (Li et al., 2015), although virtually no information is currently available
about the normal function and expression of these microRNA among non-differentiated DPSC.
The results of this study greatly expand the range of microRNA expression profiles
among DPSC to include several key regulators of MSC activity, such as miR-218 which is
known to regulate proliferation and stem cell activity through the TOB1 (transducer of ERBB2,
1) pathway (Gao et al., 2016). In addition, the role of miR-124 which may function to modulate
the Wnt/beta-catening pathway and MSC chemotaxis

although no study has yet confirmed the

expression of miR-218 in DPSC (Yue et al., 2016; Laine et al., 2012). Finally, this study may be
the first evidence of the expression of miR-27 among DPSC, which has been identified as a
critical microRNA modulating the tolerogenic response of adipose-derived MSCs (Chen et al.,
2013).
Despite the significance of these findings, some limitations must also be discussed. For
example, this study represents a small number of individual DPSC isolates and may therefore not
be representative of all DPSC isolates (Alleman et al., 2013; Hung et al., 2013). In addition, the
differential expression of microRNAs in this study may be functionally related to other factors
that have not yet been identified

although significant amounts of information and

characterization regarding these DPSC has already been identified (Young and Kingsley, 2015;
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Tomlin et al., 2016). Finally, financial and other temporal constraints limited the number of
microRNAs that could be screened which may suggest additional microRNAs that mediate the
expression of those newly identified from this study (miR-27, miR-124, miR-218) may be high
priorities for future studies of these DPSC isolates.
Conclusions
Although the transcriptional targets of these miRNAs are not yet known, it is evident that
the differential expression of some of these miRNAs (miR-27, miR-124, miR-218) may correlate
(or even contribute) to differentiation status of these isolates. More research will be needed to
determine the precise function and targets of these microRNAs to determine their effects on
DPSC differentiation, which may foster biotechnology applications for DPSC bioengineering
applications.
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Chapter 3
Pluripotent stem cell markers and microRNA expression may correlate with dental pulp stem cell
viability and proliferation rates
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Abstract
Background: Recent evidence has demonstrated that dental pulp-derived stem cells
(DPSC) may represent a source of pluripotent progenitors capable of differentiating into many
cell and tissue types. Although microRNAs are known to modulate differentiation and function
in human dental tissues, much of this research has focused selectively on tooth development. The
primary objective of this study was to evaluate the expression of microRNA in dental pulp stem
cell isolates to compare with classical biomarkers of cellular phenotypes and pluripotency
Methods: Using eight previously isolated and characterized DPSC isolates, growth and
viability were evaluated and RNA extracted for mRNA screening. DPSC biomarker and
microRNA expression was analyzed for comparison with cellular phenotypes.
Results: Evaluation of the growth and proliferation rates of each cell line resulted in
categorization of DPSC isolates into rapid, intermediate and slow doubling times, which
demonstrated higher viability among the most rapidly proliferating DPSCs. Analysis of DPSC
biomarkers (Oct-4, Sox-2, NANOG) revealed an association with total live cell count, while
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microRNA expression (miR-27, miR-218, miR-124, miR-16) appeared to be more closely
associated with cellular viability.
Conclusions: Although this study was limited to a small number of DPSC isolates, these
results suggest a more thorough investigation and evaluation of biomarkers and microRNA
expression may be necessary to elucidate the associations and complex interconnections with
DPSC viability, proliferation, differentiation and pluripotency.

Key words: dental pulp stem cells (DPSC), microRNA, biomarkers, pluripotency

List of abbreviations: dental pulp stem cells (DPSC), mesenchymal stem cell (MSC), the
Institutional Review Board (IRB), Office for the Protection of Research Subjects (OPRS),
Doubling time (DT), rapid doubling time (rDT), intermediate doubling time (iDT), slow
doubling time (sDT)
Background
Recent evidence has demonstrated that dental pulp-derived stem cells (DPSC) may
represent a source of pluripotent progenitors capable of differentiating into many cell and tissue
types [1,2] some of which may have therapeutic potential. Several key markers of pluripotency
in DPSC have been identified, including the transcription factors Oct-4, Sox-2 and NANOG
[3,4]. Although many studies have evaluated the functional effects of these transcriptional
activators and repressors, many factors that contribute to maintaining pluripotency among DPSC
remain undiscovered [5-7].
For example, recent evidence now suggests that mesenchymal stem cell (MSC)
differentiation may be regulated not only by classical stem cell-associated transcription factors
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(Sox-2, Oct-4, NANOG)

but also via transcriptional modulation by long, non-coding RNA

known as microRNA [8,9]. In fact, there is some evidence that specific microRNAs may also be
useful as biomarkers to identify and distinguish stem cells with differing therapeutic potential
[10-12]. Although an extensive body of evidence has accumulated regarding the role of
microRNAs and MSC, few (if any) studies have focused more specifically on the role of DPSC
[13].
Although microRNAs are known to modulate differentiation and function in human
dental tissues, much of this research has focused selectively on tooth development [14-16].
Developmental biology requires a thorough understanding of these mechanisms; however, recent
studies now suggest that DPSC may also be useful in bioengineering and therapeutic applications
for regenerative medicine [17-18]. Promising areas of interest include bone and neural tissue
engineering using DPSC,

although much remains to be discovered regarding the mechanisms

that control these processes [19,20].
Research from our group has evaluated classical biomarkers and other factors that may
influence the therapeutic potential of primary explants and DPSC isolates [21,22]. The most
recent study from this group may have also identified a limited number of microRNAs that may
influence DPSC pluripotency and differentiation, including miR-27, miR-124 and miR-218 [23].
Many other studies have examined the role of these microRNAs in MSC, although only a single,
recent study has examined miR-218 in DPSC and none have evaluated the concomitant presence
(or absence) of traditional biomarkers [24-26].
In order to advance the evidence in this area, the primary objective of this study was to
evaluate the expression of microRNA in dental pulp stem cell isolates to compare with classical
biomarkers of cellular phenotypes and pluripotency
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Material and Methods
Human subjects
This project was reviewed and approved by the Institutional Review Board (IRB) and
Office for the Protection of Research Subjects (OPRS) under protocol OPRS#763012-1

Vegas
originally collected using protocol OPRS#0907-

of Non-Embryonic Stem Cells

In brief, patients scheduled for extraction of third molars for Orthodontic treatment
(primarily indicated for spacing and crowding), were asked to participate. Informed Consent (and
Pediatric Assent) were provided. Exclusion criteria included refusal to participate, provide
Informed Consent/Assent, or compromised dental pulp due to injury, fracture, infection or
disease.
Following cross sectioning of the extracted tooth at the cemento-enamel junction, DPSC
were extracted from the pulp chamber using an endodontic broach and transferred to the
laboratory for culture and analysis, as previously described [27,28]. Growth for a minimum of
ten (10) passages were allowed for each DPSC isolate, as part of the direct outgrowth method
[29,30].

Growth and Proliferation
Doubling time (DT) was established for each DPSC isolate using the growth rate
measured between 1:4 passaging and achieving confluence. These data were used to characterize
three distinct categories of DPSC growth, rapid doubling time (rDT) of two to three days,
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intermediate doubling time (iDT) five to seven days, and slow doubling time (sDT) of ten to
fourteen days [21,22].

Cellular viability and Photo microscopy
Analysis of cellular viability was performed using the Trypan Blue exclusion method and
the BioRad TC20 automated cell counter, using the manufacturer recommended protocol. These
data provided both live and total cell count, allowing for the calculation of the percentage of
viable cells in each sample, as previously described [27,28,31]. Digital images of DPSC isolates
were captured using the Lionheart LX Automated Microscope and 20X objective lens.

Statistical analysis
Rates of proliferation and cellular viability were measured and these descriptive statistics
-tailed t-test. Statistical significance was set
using an alpha level ( ) =0.05.

RNA isolation and Polymerase Chain Reaction (PCR)
RNA was extracted from each DPSC isolate using Total RNA isolation reagent (TRIR)
from Molecular Research Center and the manufacturer recommended protocol [23,27]. RNA was
analyzed to determine purity using spectrophotometric absorbance readings at 260 and 280 nm
(A260:A280 ratio). All samples were required to meet the standard A260:A280 > 1.65.
Screening for mRNA expression was facilitated using the ABgene Reverse-iT One-Step
RT-PCR kit and protocol. The basic specifications were an initial reverse transcription at 47C for
30 minutes and 30 cycles of the following: Denaturation 95C, annealing 30 seconds at selected
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primer temperature (see below), Final extension 60C for 60 seconds. Results were obtained using
gel electrophoresis and visualized using ethidium bromide with a Kodak Gel Logic 100 Imaging
System. Primers were synthesized from Eurofins MWG Operon, as follows:

DPSC biomarker primers:

Oct-

-TGGAGAAGGAGAAGCTGGAGCAAAA-GGCAGATGGTCGTTTGGCTGAATA-

Optimal Tm: 71C
-ATGGGCTCTGTGGTCAAGTC-CCCTCCCAATTCCCTTGTATOptimal Tm: 65C
-GCTGAGATGCCTCACACGGAGNANO

-TCTGTTTCTTGACTGGGACCTTGTC-

Optimal Tm: 70C
-CGTTGGAACAGAGGTTGGAG-TCCTGAAAGCTGAGGGAAGOptimal Tm: 65C

microRNA screening primers:

miR-

-ATATGAGAAAAGAGCTTCCCTGTG-
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miR-

-CAAGGCCAGAGGAGGTGAG-

Optimal Tm: 65C
miR-

-TCGGGCTTGTGCTTGATCT-

miR-

-GTGCAGGGTCCGAGTG-

Optimal Tm: 67C
miR-124miR-

-ATGAATTCTCGCCAGCTTTTTCTT-ATGAATTCATTTGCATCTGCACAAACCC-

Optimal Tm: 66C
miR-

-TAGCAGCACGTAAATATTGGCG-

miR-

-TGCGTGTCGTGGAGTC-

Optimal Tm: 66C
Results
Evaluation of the growth and proliferation rates of each DPSC isolate resulted in
categorization of DPSC isolates into rapid, intermediate and slow doubling times (Table 1). The
average doubling time (DT) for the rapid DPSC was 2.2 days, which was significantly less than
the average doubling time for the intermediate (6.25 days) and slow DPSC isolates (12.1 days),
p=0.0241.
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Table 1. Analysis of DPSC growth rates.
DPSC isolate

Doubling Time

Categorization

dpsc-3882

2.6 days

rDT

dpsc-5653

2.1 days

rDT

dpsc-7089

1.9 days

rDT

rDT average: 2.2 days
range: 1.9

2.6 days

dpsc 8124

5.9 days

iDT

dpsc-17322

6.6 days

iDT

iDT average: 6.25 days
range: 5.9

6.6 days

dpsc-11418

10.2 days

sDT

dpsc-11750

13.1 days

sDT

dpsc-11836

12.9 days

sDT

sDT average: 12.1 days
range: 10.2

13.1 days

Cellular viability was then measured for each DPSC isolate to determine if any
correlations could be found with growth rates and doubling time (Table 2). In brief, the cellular
viability for the rDT DPSC isolates averaged 56%, ranging between 52% - 59%. The average
was considerable higher than those observed among the iDT DPSC isolates (37%; range 35% 39%) or sDT DPSC isolates 31%; range 29-34%), p=0.311.
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Table 2. Trypan Blue exclusion assay test for DPSC viability.
DPSC isolate

Cellular viability

Categorization

5

dpsc-3882

1.62 x 10 cells/mL TC
0.84 x 105 cells/mL LC

rDT

Viable: 52%

(2.6 days)

5

dpsc-5653

1.90 x 10 cells/mL TC
1.12 x 105 cells/mL LC

rDT

Viable: 59%

(2.1 days)

3.35 x 105 cells/mL TC

dpsc-7089

rDT

1.90 x 105 cells/mL LC

rDT

Viable: 57%

(1.9 days)

Ave: 2.29 x 105 cells/mL TC
Ave: 1.29 x 105 cells/mL LC
Average viability: 56%
3.68 x 105 cells/mL TC

dpsc 8124

1.45 x 105 cells/mL LC

iDT

Viable: 39%

(5.9 days)

5

dpsc-17322

2.90 x 10 cells/mL TC

iDT

1.00 x 105 cells/mL LC

iDT

Viable: 35%

(6.6 days)

Ave: 3.29 x 105 cells/mL TC
Ave: 1.23 x 105 cells/mL LC
Average viability: 37%
3.24 x 105 cells/mL TC

dpsc-11418

0.948 x 105 cells/mL LC

sDT

Viable: 29%

(10.2 days)

5

dpsc-11750

3.24 x 10 cells/mL TC
1.00 x 105 cells/mL LC

sDT

Viable: 31%

(13.1 days)

1.62 x 105 cells/mL TC

dpsc-11836

sDT

0.558 x 105 cells/mL LC

sDT

Viable: 34%

(12.9 days)

Ave: 2.70 x 105 cells/mL TC
Ave: 0.835 x 105 cells/mL LC
Average viability: 31%
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To more closely evaluate cellular phenotypes and morphology, as well as to evaluate the
presence of both viable and non-viable cells, digital micrographs were obtained from each DPSC
isolate (Figure 1). Briefly, these data demonstrated multiple, non-adherent DPSC cells with
fewer cells displaying signs of apoptosis (intense blebbing) among the rDT isolates (Fig. 1A.
Fig. 1C). Higher proportions of these non-viable cells were observed among the iDT (Fig. 1D.
Fig. 1H) and sDT isolates (Fig. 1. E

Fig. 1G.)

Figure 1. DIC digital photomicrographs of freshly dispersed and cultured dental pulp stem cells
-C) rapidly dividing (rDT) DPSC, (E-G) slowly dividing (sDT) DPSC, D+H
intermediately dividing DPSC. Arrows showing intense cellular blebbing (apoptosis), scale bar =
100 µm.
To evaluate the association between growth and viability, DPSC biomarkers (Oct-4, Sox2, NANOG, Nestin) and microRNAs (miR-27, miR-218, miR-124, miR-16) were evaluated
using RT-PCR for comparison with graphs of live and viable cells (Figure 2). More specifically,
the total live counts from each cell line were plotted, which revealed the highest numbers among
the rDT and iDT isolates (Fig. 2A). These data appear to correlate with the expression of
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NANOG, Sox-2 and Oct-4 among the rDT and iDT isolates

although some variability in

mRNA expression was observed (Fig. 2B).
Although mRNA expression of at least two DPSC biomarkers was noted in all rDT and
iDT isolates, the expression of all DPSC biomarkers was noted in only one DPSC isolate (dpsc7089), which was observed to have the highest overall live cell count and cell viability (Fig. 2B
and Fig 2C). In addition, Oct-4 expression was not observed in either of the iDT isolates (dpsc8124, dpsc-17322). However, the expression of Sox-2 and NANOG was observed in all of the
iDT isolates, unlike the variable expression observed among the rDT isolates.
The highest overall viability was verified among the rDT isolates (dpsc-3882, dpsc-5653,
dpsc-7089) with an average exceeding 50% (Fig. 2C). These data appear to correlate with the
expression of miR-27, which was observed only among the rDT isolates (Fig. 2D). Expression of
miR-124 was restricted to the sDT isolates, which appeared to have the lowest overall viability
(approximately 30%), with variable expression observed with miR-218. It was noted that only
miR-16 (control) expression was observed among the iDT isolates, with no expression of miR27, miR-124 or miR-218 observed.
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Figure 2. Correlation of DPSC markers with microRNA expression. A) Graphed live cell counts
from DPSC isolates demonstrated highest levels among rDT and iDT isolates. B) mRNA
expression of DPSC biomarkers revealed Oct-4, Sox-2 and NANOG among rDT isolates
(variable) and only Nestin expression among sDT isolates. C) Percentage of viable cells revealed
higher percentages among rDT isolates compared with either iDT or sDT. D) MicroRNA
expression of miR-27 was observed among rDT only, while miR-124 and miR-218 was observed
mainly among the sDT isolates.
Discussion
The primary objective of this study was to evaluate the expression of microRNA in dental
pulp stem cell isolates to compare with classical biomarkers of cellular phenotypes and
pluripotency. Evaluation of the growth and proliferation rates of each cell line resulted in
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categorization of DPSC isolates into rapid, intermediate and slow doubling times, which
demonstrated higher viability among the most rapidly proliferating DPSCs. Analysis of DPSC
biomarkers (Oct-4, Sox-2, NANOG) revealed an association with total live cell count, while
microRNA expression (miR-27, miR-218, miR-124, miR-16) appeared to be more closely
associated with viability.
These data appear to confirm recent studies that demonstrated proliferation and growth
potential among DPSC isolates to be closely linked with expression of Sox-2 and other DPSC
biomarkers, such as Oct-4 [32-34]. The results of this study also support previous findings from
this group regarding the association between doubling time (growth) and these biomarkers
[21,22,27]. In addition, these data also confirm one of the only studies to demonstrate an
association between microRNA expression (miR-218) and DPSC viability and differentiation
potential [35].
Although only limited evidence regarding DPSC and microRNAs may be available, a
growing body of evidence regarding microRNA expression and stem cell differentiation may
suggest further research in this area is warranted [36,37]. For example, miR-124 may a key
regulator of osteogenic, myogenic and neuronal differentiation in MSC

although this role has

yet to be confirmed among DPSC [38-40]. miR-218 may also function in a similar capacity, as a
key regulator of osteogenic differentiation in MSC [41].
The role of miR-27 in differentiation of other MSC may be the most thoroughly
examined of these microRNAs [24,25]. For example, miR-27 has been shown to promote
osteoblast differentiation by directly modulating transcription of several key components of the
beta-catenin/Wnt pathway [42]. miR-27 may also function to promote myeloblast differentiation
through direct and indirect modulation of Runx1 transcription [43,44]. However, miR-27 has
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also been shown to inhibit adipose differentiation and mitochondrial function via multiple
pathways in other types of adipose-derived MSC [45-47].

Conclusions
Although this study was limited to a small number of DPSC isolates, these results suggest
a more thorough investigation and evaluation of biomarkers and microRNA expression may be
necessary to elucidate the associations and complex interconnections with DPSC viability,
proliferation, differentiation and pluripotency.

Declarations
This project was reviewed and approved by the Institutional Review Board (IRB) and
Office for the Protection of Research Subjects (OPRS) under protocol OPRS#763012-1

Vegas

Competing interests
The authors declare there are no conflicts of interest.

Funding
This project was funded by the Office of Research and the Department of Advanced
Education in Orthodontics and Dentofacial Orthopedics, at the University of Nevada, Las Vegas
School of Dental Medicine.

37

Authors contributions
Karl Kingsley and Mark Whiting were responsible for experimental protocols, including
RNA isolation and PCR screening, as well as project design and funding. William J Hatton was
responsible for photo microscopy and cell imaging. All authors participated in data analysis and
manuscript preparation

38

References
1. Lima P, Aboyeji D, Orcharton M. Dental pulp stem cells in regenerative medicine. Br Dent J.
2018 May 4. doi: 10.1038/sj.bdj.2018.348. [Epub ahead of print] PMID: 29725075
2. Shetty H, Kakade A, Shetty S, Neelakantan P, Nagar S, Desai RS, Beri K.
Immunohistochemical characterization of stem cell and differentiation markers of the
dental pulp of human natal teeth. Future Sci OA. 2018 Oct 4;4(10):FSO342. doi:
10.4155/fsoa-2018-0062. eCollection 2018 Dec. PMID: 30450229 Free PMC Article
3. Liu L, Wei X, Ling J, Wu L, Xiao Y. Expression pattern of Oct-4, Sox2, and c-Myc in the
primary culture of human dental pulp derived cells. J Endod. 2011 Apr;37(4):466-72. doi:
10.1016/j.joen.2010.12.012. Epub 2011 Feb 25. PMID: 21419292
4. Kaukua N, Chen M, Guarnieri P, Dahl M, Lim ML, Yucel-Lindberg T, Sundström E,
Adameyko I, Mao JJ, Fried K. Molecular differences between stromal cell populations
from deciduous and permanent human teeth. Stem Cell Res Ther. 2015 Apr 18;6:59. doi:
10.1186/s13287-015-0056-7. PMID: 25927523
5. Liu L, Wu L, Wei X, Ling J. Induced overexpression of Oct4A in human dental pulp cells
enhances pluripotency and multilineage differentiation capability. Stem Cells Dev. 2015
Apr 15;24(8):962-72. doi: 10.1089/scd.2014.0388. Epub 2015 Jan 8. PMID: 25422984
6. Yuan J, Liu X, Chen Y, Zhao Y, Liu P, Zhao L, Han W. Effect of SOX2 on osteogenic
differentiation of dental pulp stem cells. Cell Mol Biol (Noisy-le-grand). 2017 Jan
30;63(1):41-44. doi: 10.14715/cmb/2017.63.1.8. PMID: 28234623
7. Huang CE, Hu FW, Yu CH, Tsai LL, Lee TH, Chou MY, Yu CC. Concurrent expression of
Oct4 and Nanog maintains mesenchymal stem-like property of human dental pulp cells.

39

Int J Mol Sci. 2014 Oct 15;15(10):18623-39. doi: 10.3390/ijms151018623. PMID:
25322154
8. Krstic J, Trivanovic D, Obradovic H, Kukolj T, Bugarski D, Santibanez JF. Regulation of
Mesenchymal Stem Cell Differentiation by Transforming Growth Factor Beta
Superfamily. Curr Protein Pept Sci. 2018;19(12):1138-1154. doi:
10.2174/1389203718666171117103418. PMID: 29150917
9. Huang C, Gou S, Wang L, Huang K, Liu L, Zhao W, Zheng L, Xiao J. MicroRNAs and
Peroxisome Proliferator-Activated Receptors Governing the Differentiation of
Mesenchymal Stem Cells. Curr Stem Cell Res Ther. 2016;11(3):197-207. Review.
PMID: 26018230
10. Martin EC, Qureshi AT, Dasa V, Freitas MA, Gimble JM, Davis TA. MicroRNA regulation
of stem cell differentiation and diseases of the bone and adipose tissue: Perspectives on
miRNA biogenesis and cellular transcriptome. Biochimie. 2016 May;124:98-111. doi:
10.1016/j.biochi.2015.02.012. Epub 2015 Feb 26. Review. PMID: 25726914
11. Sekar D, Saravanan S, Karikalan K, Thirugnanasambantham K, Lalitha P, Islam VI. Role of
microRNA 21 in mesenchymal stem cell (MSC) differentiation: a powerful biomarker in
MSCs derived cells. Curr Pharm Biotechnol. 2015;16(1):43-8. Review. PMID: 25564252
12. Clark EA, Kalomoiris S, Nolta JA, Fierro FA. Concise review: MicroRNA function in
multipotent mesenchymal stromal cells. Stem Cells. 2014 May;32(5):1074-82. Review.
PMID: 24860868
13. Collino F, Bruno S, Deregibus MC, Tetta C, Camussi G. MicroRNAs and mesenchymal stem
cells. Vitam Horm. 2011;87:291-320. doi: 10.1016/B978-0-12-386015-6.00033-0.
Review. PMID: 22127248

40

14. Sehic A, Tulek A, Khuu C, Nirvani M, Sand LP, Utheim TP. Regulatory roles of microRNAs
in human dental tissues. Gene. 2017 Jan 5;596:9-18. doi: 10.1016/j.gene.2016.10.009.
Epub 2016 Oct 8. Review. PMID: 27725267
15. Zhang R, Li T. Modulation of microRNAs in Tooth Root and Periodontal Tissue
Development. Curr Stem Cell Res Ther. 2018;13(2):118-124. doi:
10.2174/1574888X12666170713123647. Review. PMID: 28707582
16. Jin Y, Wang C, Cheng S, Zhao Z, Li J. MicroRNA control of tooth formation and eruption.
Arch Oral Biol. 2017 Jan;73:302-310. doi: 10.1016/j.archoralbio.2016.08.026. Epub 2016
Aug 27. Review. PMID: 27835837
17. Aurrekoetxea M, Garcia-Gallastegui P, Irastorza I, Luzuriaga J, Uribe-Etxebarria V, Unda F,
Ibarretxe G. Dental pulp stem cells as a multifaceted tool for bioengineering and the
regeneration of craniomaxillofacial tissues. Front Physiol. 2015 Oct 16;6:289. doi:
10.3389/fphys.2015.00289. eCollection 2015. Review. PMID: 26528190
18. Daltoé FP, Mendonça PP, Mantesso A, Deboni MC. Can SHED or DPSCs be used to
repair/regenerate non-dental tissues? A systematic review of in vivo studies. Braz Oral
Res. 2014;28. pii: S1806-83242014000100401. Epub 2014 Aug 21. Review. PMID:
25166769
19. Kim BC, Bae H, Kwon IK, Lee EJ, Park JH, Khademhosseini A, Hwang YS.
Osteoblastic/cementoblastic and neural differentiation of dental stem cells and their
applications to tissue engineering and regenerative medicine. Tissue Eng Part B Rev.
2012 Jun;18(3):235-44. doi: 10.1089/ten.TEB.2011.0642. Epub 2012 Mar 6. Review.
PMID: 22224548

41

20. Seong JM, Kim BC, Park JH, Kwon IK, Mantalaris A, Hwang YS. Stem cells in bone tissue
engineering. Biomed Mater. 2010 Dec;5(6):062001. doi: 10.1088/1748-6041/5/6/062001.
Epub 2010 Oct 6. Review. PMID: 20924139
21. A Young, K Kingsley . Dental Pulp Stem Cells: A review of factors that influence the
therapeutic potential of stem cell isolates. Biomaterials and Biomedical Engineering June
2015, 2(2): 61-69. DOI: 10.12989/bme.2015.2.2.061
22. Tomlin A, Nelson B, Kingsley. K. Dental Pulp Stem Cell Biomarkers for Cellular Viability
Following Long-Term Cryopreservation. Int J Cell Sys Dev Biol. 2018, 1(1): 1-6.
23. Whiting M, Kingsley K. Expression of microRNA among dental pulp stem cell (DPSC)
isolates. Current Research in Dentistry, 2019. [Online first]. DOI :
10.3844/crdsp.2018.12.18
24. Ma Y, Yao N, Liu G, Dong L, Liu Y, Zhang M, Wang F, Wang B, Wei X, Dong H, Wang L,
Ji S, Zhang J, Wang Y, Huang Y, Yu J. Functional screen reveals essential roles of miR27a/24 in differentiation of embryonic stem cells. EMBO J. 2015 Feb 3;34(3):361-78.
doi: 10.15252/embj.201489957. Epub 2014 Dec 17. PMID: 25519956
25. Xue Y, Qian H, Hu J, Zhou B, Zhou Y, Hu X, Karakhanyan A, Pang Z, Fu XD. Sequential
regulatory loops as key gatekeepers for neuronal reprogramming in human cells. Nat
Neurosci. 2016 Jun;19(6):807-15. doi: 10.1038/nn.4297. Epub 2016 Apr 25. PMID:
27110916
26. Chang K, Chen RS, Chang FH, Chen MH. Promoting dentinogenesis of DPSCs through
inhibiting microRNA-218 by using magnetic nanocarrier delivery. J Formos Med Assoc.
2018 Nov 21. pii: S0929-6646(18)30456-X. doi: 10.1016/j.jfma.2018.10.018. [Epub
ahead of print] PMID: 30472043

42

27. Alleman M, Low E, Truong K, Huang E, Hill CK, Chen TY, Deaton M, Kingsley K. Dental
pulp-derived stem cells (DPSC) differentiation in vitro into odontoblast and neural
progenitors during cell passaging is associated with alterations in cell survival and
viability. International Journal of Medicine and Biomedical Research 2013, 2(2): 133141.
28. Hung E, Lee S, Fitzgerald B, Hill CK, Kingsley K. Dental pulp-derived stem cell (DPSC)
survival and viability may correlate with specific patient demographics. Forum for Dental
Student Research and Innovation (FDSRI)/ Winter 2013, 1(3): 14-21.
29. Karamzadeh R, Eslaminejad MB, Aflatoonian R. Isolation, characterization and comparative
differentiation of human dental pulp stem cells derived from permanent teeth by using
two different methods. J Vis Exp. 2012 Nov 24;(69). pii: 4372. doi: 10.3791/4372.
PMID: 23208006
30. Bakkar M, Liu Y, Fang D, Stegen C, Su X, Ramamoorthi M, Lin LC, Kawasaki T, Makhoul
N, Pham H, Sumita Y, Tran SD. A Simplified and Systematic Method to Isolate, Culture,
and Characterize Multiple Types of Human Dental Stem Cells from a Single Tooth.
Methods Mol Biol. 2017;1553:191-207. doi: 10.1007/978-1-4939-6756-8_15. PMID:
28229417
31. Cinelli J, Ngueyn E, Kingsley K. Assessment of dental pulp stem cell (DPSC) biomarkers
following induction with bone morphogenic protein (BMP-2). Journal of Advances in
Biology and Biotechnology, 2018, 19(2): 1-12. Doi:10.9734/JABB/2018/44215
32. Xie H, Dubey N, Shim W, Ramachandra CJA, Min KS, Cao T, Rosa V. Functional
Odontoblastic-Like Cells Derived from Human iPSCs. J Dent Res. 2018 Jan;97(1):77-83.
doi: 10.1177/0022034517730026. Epub 2017 Sep 12. PMID: 28898112

43

33. Yang Y, Zhao Y, Liu X, Chen Y, Liu P, Zhao L. Effect of SOX2 on odontoblast
differentiation of dental pulp stem cells. Mol Med Rep. 2017 Dec;16(6):9659-9663. doi:
10.3892/mmdlxr.2017.7812. Epub 2017 Oct 17. PMID: 29039570
34. Liu P, Cai J, Dong D, Chen Y, Liu X, Wang Y, Zhou Y. Effects of SOX2 on Proliferation,
Migration and Adhesion of Human Dental Pulp Stem Cells. PLoS One. 2015 Oct
23;10(10):e0141346. doi: 10.1371/journal.pone.0141346. eCollection 2015. PMID:
26496354
35. Gay I, Cavender A, Peto D, Sun Z, Speer A, Cao H, Amendt BA. Differentiation of human
dental stem cells reveals a role for microRNA-218. J Periodontal Res. 2014
Feb;49(1):110-20. doi: 10.1111/jre.12086. Epub 2013 May 13. PMID: 23662917
36. Gu H, Xu J, Huang Z, Wu L, Zhou K, Zhang Y, Chen J, Xia J, Yin X. Identification and
differential expression of microRNAs in 1, 25-dihydroxyvitamin D3-induced osteogenic
differentiation of human adipose-derived mesenchymal stem cells. Am J Transl Res.
2017 Nov 15;9(11):4856-4871. eCollection 2017. PMID: 29218085
37. Hao Y, Ge Y, Li J, Hu Y, Wu B, Fang F. Identification of MicroRNAs by Microarray
Analysis and Prediction of Target Genes Involved in Osteogenic Differentiation of
Human Periodontal Ligament Stem Cells. J Periodontol. 2017 Oct;88(10):1105-1113.
doi: 10.1902/jop.2017.170079. Epub 2017 Jun 9. PMID: 28598283
38. Qadir AS, Um S, Lee H, Baek K, Seo BM, Lee G, Kim GS, Woo KM, Ryoo HM, Baek JH.
miR-124 negatively regulates osteogenic differentiation and in vivo bone formation of
mesenchymal stem cells. J Cell Biochem. 2015 May;116(5):730-42. doi:
10.1002/jcb.25026. PMID: 25424317

44

39. Qadir AS, Woo KM, Ryoo HM, Yi T, Song SU, Baek JH. MiR-124 inhibits myogenic
differentiation of mesenchymal stem cells via targeting Dlx5. J Cell Biochem. 2014
Sep;115(9):1572-81. doi: 10.1002/jcb.24821. PMID: 24733577
40. Mondanizadeh M, Arefian E, Mosayebi G, Saidijam M, Khansarinejad B, Hashemi SM.
MicroRNA-124 regulates neuronal differentiation of mesenchymal stem cells by
targeting Sp1 mRNA. J Cell Biochem. 2015 Jun;116(6):943-53. doi: 10.1002/jcb.25045.
PMID: 25559917
41. Xu JF, Yang GH, Pan XH, Zhang SJ, Zhao C, Qiu BS, Gu HF, Hong JF, Cao L, Chen Y, Xia
B, Bi Q, Wang YP. Altered microRNA expression profile in exosomes during osteogenic
differentiation of human bone marrow-derived mesenchymal stem cells. PLoS One. 2014
Dec 11;9(12):e114627. doi: 10.1371/journal.pone.0114627. eCollection 2014. PMID:
25503309
42. Wang T, Xu Z. miR-27 promotes osteoblast differentiation by modulating Wnt signaling.
Biochem Biophys Res Commun. 2010 Nov 12;402(2):186-9. doi:
10.1016/j.bbrc.2010.08.031. Epub 2010 Aug 12. PMID: 20708603
43. Feng J, Iwama A, Satake M, Kohu K. MicroRNA-27 enhances differentiation of myeloblasts
into granulocytes by post-transcriptionally downregulating Runx1. Br J Haematol. 2009
May;145(3):412-23. doi: 10.1111/j.1365-2141.2009.07632.x. Epub 2009 Mar 2. PMID:
19298589
44. Lozano-Velasco E, Contreras A, Crist C, Hernández-Torres F, Franco D, Aránega AE. Pitx2c
modulates Pax3+/Pax7+ cell populations and regulates Pax3 expression by repressing
miR27 expression during myogenesis. Dev Biol. 2011 Sep 1;357(1):165-78. doi:
10.1016/j.ydbio.2011.06.039. Epub 2011 Jul 1. PMID: 21749861

45

45. Chen KD, Goto S, Hsu LW, Lin TY, Nakano T, Lai CY, Chang YC, Weng WT, Kuo YR,
Wang CC, Cheng YF, Ma YY, Lin CC, Chen CL. Identification of miR-27b as a novel
signature from the mRNA profiles of adipose-derived mesenchymal stem cells involved
in the tolerogenic response. PLoS One. 2013 Apr 16;8(4):e60492. doi:
10.1371/journal.pone.0060492. Print 2013. PMID: 23613728
46. Kang T, Lu W, Xu W, Anderson L, Bacanamwo M, Thompson W, Chen YE, Liu D.
McroRNA-27 (miR-27) targets prohibitin and impairs adipocyte differentiation and
mitochondrial function in human adipose-derived stem cells. J Biol Chem. 2013 Nov
29;288(48):34394-402. doi: 10.1074/jbc.M113.514372. Epub 2013 Oct 16. PMID:
24133204
47. Chen SZ, Xu X, Ning LF, Jiang WY, Xing C, Tang QQ, Huang HY. miR-27 impairs the
adipogenic lineage commitment via targeting lysyl oxidase. Obesity (Silver Spring). 2015
Dec;23(12):2445-53. doi: 10.1002/oby.21319. Epub 2015 Nov 5. PMID: 26536844

46

Chapter 4: Summary and Conclusions.
The goal of this project was to assess the presence of miRNA in DPSC lines. Due to the
fact that certain miRNA have been shown to affect gene expression it is important to understand
their role as it pertains to the pluripotent potential of DPSC and ultimately the differentiation of
those specific cells.
Chapter 2 of this paper was a study of the presence of specific miRNA in our samples of
DPSC. Eight different DPSC lines were evaluated using PCR to determine that presence of mirR-16, miR-27, miR-124, and miR-218. Furthermore, it was determined there was differential
expression of miR-27, miR-124, and miR-218. With further research these results may help
further explain differentiation status of these cells.
Chapter 3 of this paper further evaluated the presence of miRNA presence in DPSC and
its correlation with other characteristics. We again used the same eight cell lines for DPSC
samples and classified them into three categories based upon proliferation rates. These categories
were rapid, intermediate, and slow dividing times with higher viability being more closely
associated with rapid proliferation. Furthermore, we analyzed the results as they correlated with
the presence of the biomarkers Oct-4, Sox-2 and NANOG. Our conclusions were that the
presence of biomarkers Oct-4, Sox-2 and NANOG were more closely connected with total live
cell count whereas the presence of miRNAs miR-27, miR-124, and miR-218 were tied more
closely to cellular viability.
Conclusions from these 2 chapters led us to believe that there is a presence of certain
miRNA in our DPSC samples. Because of this presence we can reject our null hypothesis and
accept our alternative hypothesis for questions 1 of this paper. In addition, our further analysis
has shown correlation between miRNA expression and DPSC biomarkers with cellular viability
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and total live count. Due to these results we move to reject our null hypothesis and accept our
alternative hypothesis in question 2 of this paper.

1. Can microRNAs be detected in RNA isolated from primary DPSC explant?
HA: MicroRNA will be detectable from RNA isolated from DPSC explants.
2. Is there a correlation between microRNA expression and DPSC biomarkers or cellular
phenotypes?
HA: There are correlations between microRNA expression and DPSC biomarkers or cellular
phenotypes.
Limitations and Recommendations:
As mentioned in previous chapters, one limitation for this study is the limited number of
DPSC samples that were analyzed. These limits were brought about by funding issues and
viable cell lines available to use in this study since the original samples were collected in
previous years. I would recommend gathering more samples to analyze so that we could run
statistical analysis to confirm the importance of certain miRNA found in DPSCs.
In addition, there are a limited number of studies from other research outlets to
compare our results with. Due to the vast number of different miRNA molecules that exist it is
difficult narrow down which ones to include in the study. Further research needs to be done to
determine the function of specific miRNA molecules before we look for their presence or
absence in our DPSC samples.
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